Dr. Petanceska is a graduate of the University of Belgrade in the former Yugoslavia, where she received a bachelor’s degree in molecular biology and physiology. She holds a Ph.D. in Pharmacology from New York University. Following her postdoctoral training at Rockefeller University and Cornell University in New York, she established her independent research career at the Nathan Kline Institute in Orangeburg, N.Y., and joined the faculty of New York University Medical Center. Her research focused on the role of disrupted sterol metabolism in Alzheimer’s disease pathogenesis and on the mechanisms by which estrogens and cholesterol-lowering drugs might exert neuroprotection. In 2005, Dr Petanceska joined the National Institute on Aging as a program director in the Division of Neuroscience. She is responsible for research areas that address the role of metabolic and vascular factors in normal brain aging and in Alzheimer’s disease. Dr. Petanceska is NIA's Representative to the NIH Common Fund Epigenomics Program. She is also involved in the development and oversight of NIA's Alzheimer's Disease Translational Research Program, composed of a series of funding initiatives for drug discovery and preclinical drug development for AD, mild cognitive impairment, and age-related cognitive decline.
the role of metabolic and vascular factors in normal brain aging and in Alzheimer’s disease